Patents by Inventor Kosuke NOGUCHI

Kosuke NOGUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220388429
    Abstract: A body-size class specification device of the present invention comprises a class feature-quantity information memorizing section to memorize class feature-quantity information to correlate plural classes for classifying a body size according to a dimension ratio of prescribed parts of a body with plural prescribed feature quantities for characterizing the plural classes, a first input section as an example of a feature-quantity acquiring section to acquire feature quantity of an object person to be specified for the class, an eye-height measuring section and an upper-body-length-ratio processing section, and a class specifying section to specify the class corresponding to the feature quantity of the object person acquired by the feature-quantity acquiring section based on the class feature-quantity information memorized by the class feature-quantity information memorizing section.
    Type: Application
    Filed: June 2, 2022
    Publication date: December 8, 2022
    Applicant: MAZDA MOTOR CORPORATION
    Inventors: Kosuke NOGUCHI, Yoshito HIRATA, Hiroki UEMURA, Tomonori OHTSUBO
  • Patent number: 11285195
    Abstract: The pharmaceutical composition for inhibiting expression of CD47 in tumor cells provided by the present invention contains: exosomes produced by cultured tumor cells in an amount effective for inhibiting expression of the CD47; and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: March 29, 2022
    Inventors: Ikuhiko Nakase, Kosuke Noguchi, Nahoko Baileykobayashi, Tetsuhiko Yoshida
  • Publication number: 20180214528
    Abstract: The pharmaceutical composition for inhibiting expression of CD47 in tumor cells provided by the present invention contains: exosomes produced by cultured tumor cells in an amount effective for inhibiting expression of the CD47; and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: January 26, 2018
    Publication date: August 2, 2018
    Inventors: Ikuhiko NAKASE, Kosuke NOGUCHI, Nahoko BAILEYKOBAYASHI, Tetsuhiko YOSHIDA